Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brain

por Bol, K. F., Peeters, E., van Herpen, C. M. L., Westdorp, H., Aarntzen, E. H. J. G.
Publicado 2023

A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer

por Desar, I M E, Timmer-Bonte, J N H, Burger, D M, van der Graaf, W T A, van Herpen, C M L
Publicado 2010

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced s...

por van Herpen, C M L, Eskens, F A L M, de Jonge, M, Desar, I, Hooftman, L, Bone, E A, Timmer-Bonte, J N H, Verweij, J
Publicado 2010

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

por Willemsen, A. E. C. A. B., Knapen, L. M., de Beer, Y. M., Brüggemann, R. J. M., Croes, S., van Herpen, C. M. L., van Erp, N. P.
Publicado 2017

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

por Gregorc, V, Santoro, A, Bennicelli, E, Punt, C J A, Citterio, G, Timmer-Bonte, J N H, Caligaris Cappio, F, Lambiase, A, Bordignon, C, van Herpen, C M L
Publicado 2009

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study

por Hamberg, P, Boers-Sonderen, M J, van der Graaf, W T A, de Bruijn, P, Suttle, A B, Eskens, F A L M, Verweij, J, van Herpen, C M L, Sleijfer, S
Publicado 2014

Informal caregiver well-being during and after patients’ treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study

por Langenberg, S. M. C. H., Poort, H., Wymenga, A. N. M., de Groot, J. W., Muller, E. W., van der Graaf, W. T. A., Prins, J. B., van Herpen, C. M. L.
Publicado 2020

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locor...

por van Herpen, C M L, Mauer, M E, Mesia, R, Degardin, M, Jelic, S, Coens, C, Betka, J, Bernier, J, Remenar, E, Stewart, J S, Preiss, J H, van den Weyngaert, D, Bottomley, A, Vermorken, J B
Publicado 2010

Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results

por Schoffelen, R, Boerman, O C, Goldenberg, D M, Sharkey, R M, van Herpen, C M L, Franssen, G M, McBride, W J, Chang, C-H, Rossi, E A, van der Graaf, W T A, Oyen, W J G
Publicado 2013

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study

por Desar, I.M.E., ter Voert, E.G.W., Hambrock, Th., van Asten, J.J.A., van Spronsen, D.J., Mulders, P.F.A., Heerschap, A., van der Graaf, W.T.A., van Laarhoven, H.W.M., van Herpen, C.M.L.
Publicado 2011

Prospective practice survey of management of cetuximab-related skin reactions

por Lugtenberg, R. T., Boers-Doets, C. B., Witteveen, P. O., van Herpen, C. M. L., Wymenga, A. N. M., de Groot, J. W. B., Hoeben, A., del Grande, C., van Doorn, B., Koldenhof, J. J., Driessen, C. M. L., Gelderblom, H.
Publicado 2020

PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports

por Uijen, M. J. M., Derks, Y. H. W., Merkx, R. I. J., Schilham, M. G. M., Roosen, J., Privé, B. M., van Lith, S. A. M., van Herpen, C. M. L., Gotthardt, M., Heskamp, S., van Gemert, W. A. M., Nagarajah, J.
Publicado 2021

[(89)Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

por van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., Menke-van der Houven van Oordt, C. W.
Publicado 2019

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [(68)Ga]Ga-DOTA-E-[c(RGDfK)](2) PET/CT

por Lobeek, D., Rijpkema, M., Terry, S. Y. A., Molkenboer-Kuenen, J. D. M., Joosten, L., van Genugten, E. A. J., van Engen-van Grunsven, A. C. H., Kaanders, J. H. A. M., Pegge, S. A. H., Boerman, O. C., Weijs, W. L. J., Merkx, M. A. W., van Herpen, C. M. L., Takes, R. P., Aarntzen, E. H. J. G., Oyen, W. J. G.
Publicado 2020